Open in interactive viewer → charts, metric popovers & call review

BIO-key Has a Killer App and a Three-Quarter-Old Hardware Order

License revenue up 39%, gross margin at 90%, stock down 57% — the pivot from tokens to AI agents is real, the revenue recognition is not yet
BKYI · Earnings Call · 2026-11-13

BIO-key's killer app is real. The revenue is still a promise.

A 90% gross margin on a denominator that won't move

BIO-key's third quarter is a study in a small software company looking excellent and stuck in the same print. License fee revenue rose 39% to $1.28M and carried 86% of the top line versus 59% a year ago. “License fee revenue grew 39% year-over-year, and that high-margin recurring revenue lifted our gross margin to 90% from 77% a year ago” — Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13. The margin has climbed sequentially all year — 83%, then 87%, then 90% — and the trailing figure now sits at 87.2%, up 14.5 points year over year. Operating loss narrowed to $820K from $892K; the nine-month net loss improved 42% to $1.67M on revenue of $5.55M, up 14%. Then the other side. Total revenue was $1.48M, down 4%. Hardware collapsed to $12K from $364K. And that is where the story stops being arithmetic and becomes behavior. Jack Vander Aarde asked directly whether a big hardware order had slipped: “Starting in Q2, we had a larger hardware order that we were expecting for an international customer... That has just been pushed” — Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13. That is the third straight quarter in which a fully-reserved, all-margin, all-cash hardware order has been one quarter away. In August it was "pushed into the second half." Now it ships in tranches of 60 and 100 units — not lost, management insists, just "dribbling."

What actually changed: two new doors for identity-bound biometrics

For two years BIO-key has sold one idea — a fingerprint instead of a phone or a token — into defense ministries and foreign banks. This quarter the idea cracked two genuinely new rooms. First, a US casino resort. Employees on a gaming floor cannot carry phones; compliance still demands multi-factor. Inbound web lead to closed deal in under 60 days, a multi-six-figure three-year contract won against much larger competitors, and a beachhead in casino and hospitality — with the customer taking BIO-key to an industry event in January. Second, and louder: management now frames verified-human approval of AI-driven actions as its killer app, arguing machine identities outnumber human ones by 100:1. The Passkey:YOU authenticator earned full FIDO certification in September and is in final testing. The broader agentic AI pitch is that a biometric approval can be bolted onto an existing identity stack — Okta, Ping, SailPoint — without a rip-and-replace. That is not a lonely thesis this week. Across the recent reporters, AI agents surface everywhere from Recruit Holdings to Repay to Telecom Italia, and the global theme list has carried personal AI agents in its top tier. BIO-key's distribution arms for the same wave are new too: the cybersecurity division of Spain's Prosegur folding BIO-key into its portfolio, a new Saudi subsidiary staffed with its own people, and a partnership with Al Majlis Group across the Arabian Gulf. Third-quarter EMEA revenue grew 39% with license fees more than doubling.

The pattern that matters: "solid finish" as a genre

Here is the tension. In November 2025, asked about breakeven, the CEO said “Absolutely. No question in my mind. I do see it.” — Michael DePasquale, Chairman and Chief Executive Officer (CEO) · 2025-11-14 In March 2026: “our goal this year... is to be breakeven or profitable and to be cash flow positive” — Michael DePasquale, Chairman and CEO · 2026-03-31. In August, profitability was promised for the back half. On this call the target slid to "approaching" Q1 2027 — the seasonally strongest quarter, when roughly $1.2M of renewals land, including a largest customer worth more than $1M a year. What is different is that the pipeline language has hardened even as the timing has slipped: seven-figure Middle East banking and government deals, eight new Middle East customers in roughly seven months, a national biometric initiative with the Central Bank of Jordan, and a Portuguese security agency deployment through partner Visualforma. “I'm really expecting significant growth, and I still think even in the fourth quarter here, we're going to see very strong finish” — Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13. Pressed for a benchmark, the CFO read off Q4 revenue of $1.188M, $1.286M and $1.593M for the last three years, and the CEO turned explicit:

We'll have significant growth over that in this fourth quarter. Yes. And it will be significant.

Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13
Note also what has quietly left the script. The public sector megaphone, the NASDAQ suspension, the Swivel-to-BIO-key product transition, the reserve-inventory campaign — all were top-of-mind company keywords inside the last four quarters. Inventory is now a footnote; the delisting is resolved. What replaced them is a story about agents and casinos. That substitution is the real content of the quarter.

Cash, receivables, and a $3 million price tag

The balance sheet genuinely improved: the note is retired (only a ~EUR 12,000 loan remains), working capital went from $0.8M to $3.1M, and there is $2.2M of cash against a roughly $3.05M market cap — a software company with 90% gross margins valued at 0.7x revenue. But accounts receivable of $2.35M against $1.48M of quarterly revenue should give pause: receivables equal 90% of revenue, up sharply year over year, and a private investor on the call pushed exactly on that. Management's answer was that Q4 could be cash-flow breakeven on collections alone, with the caveat “It is timing of collections... Keep in mind, all this business comes through partners, and so, we are always cautious about collections” — Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13. In a channel model, that is a risk the company does not own. The tape is unforgiving: BKYI is down 57.4% over 90 days from a $5.00 July peak, and the full history is a reverse-split-scarred negative. Asked whether insiders would buy once the window opens, the CEO gave one of the shortest answers of the call: “Yeah, I think you will.” — Mike DePasquale, Chairman and Chief Executive Officer · 2026-11-13 The verdict. This is no longer a story about whether the technology works — a casino floor, a central bank and a defense base are reasonable proof. It is a story about whether lumpy, partner-led, six-to-seven-figure deals can be recognized on a schedule management controls. Three quarters of pushed hardware and a slid profitability date say not yet. One clean quarter — casino revenue booked, a $1.2M renewal quarter behind it — would reprice the whole thing.